Triple

T667625
Position Surface form Disambiguated ID Type / Status
Subject European Directorate for the Quality of Medicines & HealthCare E12899 entity
Predicate oversees P46 FINISHED
Object Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme
The Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme is a regulatory system that certifies the quality and compliance of pharmaceutical substances with European Pharmacopoeia standards, facilitating their use and acceptance across multiple countries.
E12899 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme | Statement: [European Directorate for the Quality of Medicines & HealthCare, oversees, Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme
Context triple: [European Directorate for the Quality of Medicines & HealthCare, oversees, Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme]
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • C. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • E. Clinical Practices of the University of Pennsylvania
    Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme
Triple: [European Directorate for the Quality of Medicines & HealthCare, oversees, Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme]
Generated description
The Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme is a regulatory system that certifies the quality and compliance of pharmaceutical substances with European Pharmacopoeia standards, facilitating their use and acceptance across multiple countries.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme
Target entity description: The Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme is a regulatory system that certifies the quality and compliance of pharmaceutical substances with European Pharmacopoeia standards, facilitating their use and acceptance across multiple countries.
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • C. European Directorate for the Quality of Medicines & HealthCare chosen
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • E. Clinical Practices of the University of Pennsylvania
    Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493355dec819098d4244b2fa34885 completed March 1, 2026, 7:27 p.m.
NER Named-entity recognition batch_69a49ff7ca788190bef58ce46849b9d0 completed March 1, 2026, 8:22 p.m.
NED1 Entity disambiguation (via context triple) batch_69a5c39d11508190a3bd0f118d122e1a completed March 2, 2026, 5:06 p.m.
NEDg Description generation batch_69a5c486463c8190905f9b0cbc0ba053 completed March 2, 2026, 5:10 p.m.
NED2 Entity disambiguation (via description) batch_69a5ce6be0b081909067962eef2ba7a2 completed March 2, 2026, 5:52 p.m.
Created at: March 1, 2026, 7:36 p.m.